142 related articles for article (PubMed ID: 2471806)
1. The type-specific epitopes of the Epstein-Barr virus nuclear antigen 2 are near the carboxy terminus of the protein.
Rowe DT; Clarke JR
J Gen Virol; 1989 May; 70 ( Pt 5)():1217-29. PubMed ID: 2471806
[TBL] [Abstract][Full Text] [Related]
2. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
Maunders MJ; Petti L; Rowe M
J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
[TBL] [Abstract][Full Text] [Related]
3. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an Epstein-Barr virus nuclear antigen 2 variant (EBNA 2B) by specific sera.
Sauter M; Mueller-Lantzsch N
Virus Res; 1987 Aug; 8(2):141-52. PubMed ID: 2823499
[TBL] [Abstract][Full Text] [Related]
5. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
Young LS; Yao QY; Rooney CM; Sculley TB; Moss DJ; Rupani H; Laux G; Bornkamm GW; Rickinson AB
J Gen Virol; 1987 Nov; 68 ( Pt 11)():2853-62. PubMed ID: 2824665
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma.
Chen YY; Chang KL; Chen WG; Shibata D; Hayashi K; Weiss LM
Lab Invest; 1998 Jul; 78(7):877-82. PubMed ID: 9690565
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.
Sample J; Young L; Martin B; Chatman T; Kieff E; Rickinson A; Kieff E
J Virol; 1990 Sep; 64(9):4084-92. PubMed ID: 2166806
[TBL] [Abstract][Full Text] [Related]
8. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1.
Ambinder RF; Mullen MA; Chang YN; Hayward GS; Hayward SD
J Virol; 1991 Mar; 65(3):1466-78. PubMed ID: 1847464
[TBL] [Abstract][Full Text] [Related]
9. The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines.
Chen MR; Tsai CH; Wu FF; Kan SH; Yang CS; Chen JY
J Gen Virol; 1999 Feb; 80 ( Pt 2)():447-455. PubMed ID: 10073707
[TBL] [Abstract][Full Text] [Related]
10. The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure.
Inoue N; Harada S; Honma T; Kitamura T; Yanagi K
Virology; 1991 May; 182(1):84-93. PubMed ID: 1850915
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I.
Sabbatini A; Bombardieri S; Migliorini P
Eur J Immunol; 1993 May; 23(5):1146-52. PubMed ID: 8386666
[TBL] [Abstract][Full Text] [Related]
12. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a latent protein encoded by the large internal repeats and the BamHI Y fragment of the Epstein-Barr virus (EBV) genome.
Sauter M; Boos H; Hirsch F; Mueller-Lantzsch N
Virology; 1988 Oct; 166(2):586-90. PubMed ID: 2845663
[TBL] [Abstract][Full Text] [Related]
14. Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA.
Ambinder RF; Shah WA; Rawlins DR; Hayward GS; Hayward SD
J Virol; 1990 May; 64(5):2369-79. PubMed ID: 2157891
[TBL] [Abstract][Full Text] [Related]
15. Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection.
Buisson M; Morand P; Genoulaz O; Bourgeat MJ; Micoud M; Seigneurin JM
J Gen Virol; 1994 Feb; 75 ( Pt 2)():431-7. PubMed ID: 8113767
[TBL] [Abstract][Full Text] [Related]
16. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
[TBL] [Abstract][Full Text] [Related]
17. Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.
Milman G; Scott AL; Cho MS; Hartman SC; Ades DK; Hayward GS; Ki PF; August JT; Hayward SD
Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6300-4. PubMed ID: 2412231
[TBL] [Abstract][Full Text] [Related]
18. The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression.
Walling DM; Perkins AG; Webster-Cyriaque J; Resnick L; Raab-Traub N
J Virol; 1994 Dec; 68(12):7918-26. PubMed ID: 7966582
[TBL] [Abstract][Full Text] [Related]
19. Identification of major histocompatibility complex class II-restricted antigens and epitopes of the Epstein-Barr virus by a novel bacterial expression cloning approach.
Milosevic S; Behrends U; Adhikary D; Mautner J
J Virol; 2006 Nov; 80(21):10357-64. PubMed ID: 17041216
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of fusion proteins of Epstein-Barr virus nuclear antigens in E. coli and their antigenicity.
Inoue N; Harada S; Yanagi K
J Virol Methods; 1991; 31(2-3):301-14. PubMed ID: 1713918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
